This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
broker-rating: Archive
Is Starbucks (SBUX) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Starbucks (SBUX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SBUXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in ARKO (ARKO) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for ARKO (ARKO) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ARKONegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think ServiceNow (NOW) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), ServiceNow (NOW) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
NOWNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is SkyWater Technology (SKYT) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in SkyWater Technology (SKYT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
SKYTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Cameco (CCJ): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Cameco (CCJ). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CCJNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Newmont (NEM) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Newmont (NEM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
NEMNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Synchronoss (SNCR) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Synchronoss (SNCR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SNCRPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Agnico (AEM) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Agnico (AEM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
AEMNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Deckers (DECK) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Deckers (DECK) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
DECKPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Walmart (WMT) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Walmart (WMT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
WMTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think TJX (TJX) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for TJX (TJX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
TJXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is DraftKings (DKNG) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for DraftKings (DKNG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
DKNGNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Apple (AAPL): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Apple (AAPL). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
AAPLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Broadwind Energy (BWEN): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Broadwind Energy (BWEN) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BWENNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Hercules Capital (HTGC) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Hercules Capital (HTGC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
HTGCNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Vertiv (VRT) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Vertiv (VRT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
VRTNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in APTIV HLDS LTD (APTV): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for APTIV HLDS LTD (APTV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
APTVNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Lam Research (LRCX) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Lam Research (LRCX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
LRCXPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Amazon (AMZN) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Amazon (AMZN). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
AMZNNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Nvidia (NVDA) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Nvidia (NVDA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
NVDAPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Humacyte, Inc. (HUMA) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Humacyte, Inc. (HUMA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
HUMANegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See M/I Homes (MHO) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), M/I Homes (MHO) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
MHONegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Onto Innovation (ONTO) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Onto Innovation (ONTO). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ONTOPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
High Tide (HITI) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), High Tide (HITI) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
HITIPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Crocs (CROX) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Crocs (CROX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CROXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth